Criticism of the EU’s proposed approach to regulating endocrine active substances reached new heights this summer when senior scientists — editors of 14 leading toxicology and pharmacology journals — emphasized the European Commission’s approach is being driven by unscientific precaution, “defying common sense [and] well-established science and risk assessment principles.” Read the jointly authored editorial […]
About Emily Tipaldo
Manager, Regulatory & Technical Affairs | American Chemistry CouncilEndocrine disruption, risk-based decision making and transatlantic regulatory coherence
There’s an important and ongoing debate in the U.S. and the EU about chemicals that may interact with the endocrine system to cause harmful effects in wildlife or on human health. In this post, we’ll work to answer some of the key questions driving the debate: What are endocrine disruptors? What does the latest science […]
- On the road with #ACCaugust 3.0
- In the zone: Appalachian region could become a major center of petrochemicals and plastics manufacturing
- Marine litter: Let’s stay focused on solutions
- Chemical industry achieves record-setting process safety gains
- How can we fix our nation’s infrastructure problems? Put competition to work
